833-2263234 (USA Toll-free) +1-224-345-1927 (USA) +86-13250544625(Intl) info@editxor.com
在线客服
[Weekly News] Genome-Wide CRISPR Screening: Uncovering New Host Factors to Optimize Rotavirus Vaccine

[Weekly News] Genome-Wide CRISPR Screening: Uncovering New Host Factors to Optimize Rotavirus Vaccine

EDITGENE focuses on CRISPR technology and is dedicated to providing the most efficient technical services for CRISPR-related research, gene function studies, in vitro diagnostics, and therapeutic research.

[Literature Review] Unlocking CRISPR-Cas12a's Full Potential: Enhancing Trans-Cleavage with Variants

[Literature Review] Unlocking CRISPR-Cas12a's Full Potential: Enhancing Trans-Cleavage with Variants

EDITGENE offers CRISPR-based FASST detection technology and various CRISPR detection reagents. With years of technical development, we guarantee quality and prompt delivery!

[Literature Review] Gene Knockout of ERAP1 Provides New Insights for Optimizing Tumor Immunotherapy

[Literature Review] Gene Knockout of ERAP1 Provides New Insights for Optimizing Tumor Immunotherapy

EDITGENE, specialized in CRISPR technology for years, has upgraded our Bingo™ platform to offer more precise and efficient gene point mutation services. This new development provides researchers and companies with advanced solutions for creating high-quality editing cells.

[Weekly News] CRISPR Screening Revealing TMEM106B as a Mediator of an ACE2-Independent Infection Path

[Weekly News] CRISPR Screening Revealing TMEM106B as a Mediator of an ACE2-Independent Infection Path

EDITGENE focuses on CRISPR technology and is dedicated to providing the most efficient technical services for CRISPR-related research, gene function studies, in vitro diagnostics, and therapeutic research.

1 2 3 4 5 6 7 8 9 10 11 Next